Titre :

Prevalence and risk factors of nonalcoholic fatty liver disease and advanced fibrosis in general population: the french nationwide nash-co study

Auteur(s) :

Nabi, Oumarou [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Lacombe, Karine [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Boursier, Jerome [Auteur]
Hémodynamique, Interaction Fibrose et Invasivité tumorales Hépatiques [HIFIH]
Mathurin, Philippe [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Zins, Marie [Auteur]
Cohortes épidémiologiques en population [CONSTANCES]
Serfaty, Lawrence [Auteur]
Pôle des Pathologies Digestives Hépatiques et Transplantation [Hôpital Hautepierre-Strasbourg]

Titre de la revue :

Gastroenterology

Nom court de la revue :

Gastroenterology

Numéro :

159

Pagination :

P791-793

Date de publication :

2020-05-03

ISSN :

1528-0012

Mot(s)-clé(s) en anglais :

Obesity
Type 2 Diabetes
Fatty Liver Index
Forns Index

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

The burden of nonalcoholic fatty liver disease (NAFLD) and advanced fibrosis has not been reported so far at a nationwide level in Europe. According to a meta-analysis, the prevalence of NAFLD in European countries ranged ...
Lire la suite >The burden of nonalcoholic fatty liver disease (NAFLD) and advanced fibrosis has not been reported so far at a nationwide level in Europe. According to a meta-analysis, the prevalence of NAFLD in European countries ranged from 4% to 50%, reflecting the heterogeneity of study populations. 1 The French CONSTANCES population-based cohort was designed as a large representative sample for age, gender, and socioeconomic status of the French adult population. 2 The present study was aimed to assess the prevalence of NAFLD and advanced fibrosis in the CONSTANCES cohort by using noninvasive markers, and to examine risk factors associated with these conditions.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

CHU Lille
Inserm
Université de Lille

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Date de dépôt :

2021-07-06T12:47:53Z
2024-01-24T13:16:46Z